The specific hypotheses are (a) CBD has anti-inflammatory effects by decreasing M1, Th-1, Th-17, and IRS profiles and enhancing Treg and CIRS functions; and (b) CBD attenuates the increased M1, Th-1, Th-17, and IRS responses in depression. The gene discussed is NELFCD; the disease is depressive disorder.